🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be a 2-week oral dose study of PF 04991532, performed in patients...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-12
Trial ID
NCT01469065
Treatments Being Tested
The purpose of this study is to evaluate the excretion balance, metabolic p...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-11
Trial ID
NCT01469481
Treatments Being Tested
B2611003 is designed to study how safe and effective an investigational med...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-06
Trial ID
NCT01338870
B2611002 is designed to study how safe and effective an investigational med...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-06
Trial ID
NCT01336738
Treatments Being Tested
The purpose of this study is to characterize the safety, tolerability, phar...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-04
Trial ID
NCT01102673
Treatments Being Tested
This study is designed to compare the pharmacokinetics of two different lot...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-07
Trial ID
NCT01388829
Treatments Being Tested
The primary purpose of this study is to evaluate the pharmacokinetics, safe...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-07
Trial ID
NCT01370343
Treatments Being Tested
The purpose of this study is to characterize the safety, tolerability, phar...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-06
Trial ID
NCT01129258
Treatments Being Tested
The primary purpose of this study is to evaluate the pharmacokinetics, safe...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-07
Trial ID
NCT01369602
Treatments Being Tested
This study is to investigate the safety, tolerability and pharmacokinetics ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-06
Trial ID
NCT01369277
Treatments Being Tested